IMDX SEC Filings: 8-K, 10-Q, S-3 & 424B

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 10, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 13, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 26, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 10, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 12, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Insight Molecular Diagnostics Inc. Enters into Amendment No. 2 to the Chronix Merger Agreement

Sep 21, 2026

8-K

Insight Molecular Diagnostics (iMDx) Reports Q2 2026 Results and Progress on FDA Review of GraftAssureDx

Aug 10, 2026

8-K

Insight Molecular Diagnostics Inc. Announces Results of 2026 Annual Meeting of Shareholders

Jun 17, 2026

8-K

Insight Molecular Diagnostics (iMDx) Reports Q1 2026 Results and Progress Toward GraftAssureDx Commercialization

May 13, 2026

8-K/A

Specimen Collection Agreement Signed for GraftAssureCore Test with Quest Diagnostics

May 13, 2026

8-K

Insight Molecular Diagnostics Inc. Files Corrected Bylaws

Apr 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

Feb 11, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 10,606,632 | Warrants amount: 3,069,926

Apr 8, 2025

424B5

Feb 10, 2025

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,461,138

Oct 22, 2024

424B5

ATM | Offering amount: $7,500,000

Aug 9, 2024

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 5,419,788 | Warrants amount: 342,888

Jun 4, 2024

Registrations

TYPE

HEADLINE

FILED AT

S-8

Insight Molecular Diagnostics Inc. Announces Second Amendment to 2018 Equity Incentive Plan

Jul 24, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Aug 18, 2025

S-1

SHARE RESALE REGISTRATION

Mar 31, 2025

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 24, 2025

S-3/A

SHARE RESALE REGISTRATION | Shares amount: 3,461,138 | Share price: $3.12 EFFECTIVE

Oct 18, 2024

S-3

SHARE RESALE REGISTRATION | Shares amount: 3,461,138 | Share price: $3.12 EFFECTIVE

Oct 16, 2024

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 30, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

May 14, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 14, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Sep 25, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 29, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SILVERMAN LOU (Reporting)

Jul 6, 2026

Last Andrew J. (Reporting)

Jul 6, 2026

Arno Andrew (Reporting)

Jul 6, 2026

SILVERMAN LOU (Reporting)

Jun 15, 2026

Last Andrew J. (Reporting)

Jun 15, 2026

Arno Andrew (Reporting)

Jun 15, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 8, 2025

CORRESP

Form CORRESP - Correspondence

Apr 4, 2025

LETTER

Form UPLOAD - SEC-generated letter

Apr 3, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Oct 22, 2024

CORRESP

Form CORRESP - Correspondence

Oct 21, 2024

LETTER

Form UPLOAD - SEC-generated letter

Oct 17, 2024

Insight Molecular Diagnostics Inc. IMDX · SEC Filings